News | February 26, 2015

Proton Therapy Driving Radiotherapy Market Growth Globally in 2015 and Beyond

Increasing incidence of cancers, replacement of older radiotherapy systems driving demand in U.S., abroad

February 26, 2015 — MarketReportsOnline.com adds "Global Radiation Therapy Market Report: 2015 Edition" report that says worldwide radiation therapy market has shown significant growth over the past few years, with North America as the highly competitive and largest market for radiotherapy devices.

Europe is the second largest consumer of radiotherapy devices market. Although demand for radiotherapy devices slowed down in Europe in 2012, the region picked up in 2013. On the other hand, Asia Pacific's radiotherapy market has enjoyed a tremendous growth rate during last few years. As per the report "Global Radiation Therapy Market: 2015 Edition", the proton therapy market posed a very strong growth and will continue for the foreseeable future. It also indicates that the demand for proton beam therapy will be high in the future thereby resulting in increasing expenditure on radiotherapy treatment. Moreover, the increasing number of cancer patients, rapid change in cancer treatment technology and emerging healthy reimbursement plans will continue to enhance the demand for radiotherapy equipments and products.

Radiotherapy is a treatment procedure that involves the use of high-energy radiation. Nowadays, new treatment techniques such as image guided radiation therapy (IGRT), proton therapy; brachytherapy and stereotactic radiation therapy are being increasingly adopted. Moreover, due to the less risk in proton therapy treatment, it has become the most preferred option for treating cancer. Further, it is projected that the IGRT market will grow at a stronger pace than the overall radiation therapy market as it reduces the long-term treatment side effects.

The United States is the largest market of radiotherapy devices globally. The U.S. market growth is mainly driven by the increasing incidence of cancers, replacements of older radiotherapy systems and reimbursement levels for radiation therapy.

Demand for radiotherapy devices in the Asia Pacific region has shown significant growth, mainly driven by China. The key factors driving the growth of the radiation therapy market include higher incidence of cancer, rising healthcare expenditures, rise in aging population and steady rise in global gross domestic product (GDP). The major issues faced by the market include stringent regulations and expensive treatments.

The increasing competition in the radiotherapy market has been analyzed on number of factors: proton therapy market, installed base and new orders. The report presents some of the major drivers, trends and challenges being faced by the market. It also discusses the company profiles of the top four players in the radiation therapy market:  Varian, Siemens, Elekta and Accuray.

For more information: www.marketreportsonline.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init